From sequencing the first human genome to conducting some of the earliest work in understanding the human gut microbiome, JCVI researchers are pioneers in mammalian genomics. Our work continues as we advance new methods and understanding for detecting cancers at their earliest stages, universal flu vaccines, and autoimmune diseases like multiple sclerosis.

Learn More

JCVI’s leadership and expertise began with microbial genomics. Our world is teeming with microbes and we are scouring the oceans, soil, and human body to learn how they affect all these environments.

Learn More

Infectious disease is the second leading cause of death worldwide. At JCVI we are tackling influenza, yellow fever, malaria, and other vexing infectious diseases with the goal of better understanding and enabling new treatments.

Learn More

After constructing the first synthetic bacterial cell and the first minimal bacterial cell, JCVI scientists are using the groundbreaking techniques used in these milestones to construct synthetic flu vaccines, develop unique new sources of insulin, and more efficient means to produce algae-based biofuels.

Learn More